Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
(NOT-GM-20-017)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Nursing Research
Office of Research on Women's Health
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional)
(PAR-20-119)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt Date(s):
July 27, 2020; November 25, 2020; March 25, 2021; July 26, 2021; November 26, 2021; March 25, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed)
(RFA-AG-21-008)
National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s):
May 18, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)
(RFA-AI-20-008)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
September 10, 2020
All applications s are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
(RFA-AI-20-009)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
May 29, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
(RFA-AI-20-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
June 15, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Contraceptive Development Research Centers (CDRC) Program (P50 Clinical Trial Optional)
(RFA-HD-21-011) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s):
January 6, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
(RFA-MH-20-128)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Application Receipt Date(s):
September 3, 2020 and September 2, 2021
No late applications will be accepted for this Funding Opportunity Announcement.